Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers.

about

Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers.

Item

http://www.wikidata.org/entity/Q39678636

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Lung Delivery of Indacaterol a ...... QMF149 in Healthy Volunteers.

@en

Lung Delivery of Indacaterol a ...... QMF149 in Healthy Volunteers.

@nl

type

Item

label

Lung Delivery of Indacaterol a ...... QMF149 in Healthy Volunteers.

@en

Lung Delivery of Indacaterol a ...... QMF149 in Healthy Volunteers.

@nl

prefLabel

Lung Delivery of Indacaterol a ...... QMF149 in Healthy Volunteers.

@en

Lung Delivery of Indacaterol a ...... QMF149 in Healthy Volunteers.

@nl

P1476

Lung Delivery of Indacaterol a ...... QMF149 in Healthy Volunteers.

@en

P2093

Axel Juan

http://www.w3.org/2001/XMLSchema#string

Günther Kaiser

http://www.w3.org/2001/XMLSchema#string

Hisanori Hara

http://www.w3.org/2001/XMLSchema#string

Sanjeev Khindri

http://www.w3.org/2001/XMLSchema#string

Soniya S Vaidya

http://www.w3.org/2001/XMLSchema#string

Surendra Machineni

http://www.w3.org/2001/XMLSchema#string

Suzanne Maahs

http://www.w3.org/2001/XMLSchema#string

P2860

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.

Why particle size should affect clinical response to inhaled therapy.

Bioavailability and metabolism of mometasone furoate: pharmacology versus methodology.

Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.

Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma.

Improper inhaler technique is associated with poor asthma control and frequent emergency department visits

Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium.

Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma.

Metabolism and pharmacokinetics of indacaterol in humans.

Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: workshop summary report.

P304

285-295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPDD.245

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27310329

http://www.w3.org/2001/XMLSchema#string